The Intra Abdominal Infection Market Share is projected to grow significantly, reflecting the industry's response to rising infection rates and advancements in treatment modalities. With a current market size estimated at USD 4.795 billion in 2024, this segment is set to witness a surge as healthcare providers and pharmaceutical companies align their strategies to cater to the growing demand...